ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1368

PMN Reactivity Contribute to Acute Onset Joint Inflammation By Increasing CXCL8 Production in Joints of RA Patients with Anti-Collagen II Antibodies

Vivek Anand Manivel1, Azita Sohrabian2 and Johan Rönnelid3,4, 1Immunology, Genetics and Pathology, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 2Department of Immunology Genetics and Pathology,Uppsala University, Uppsala, Sweden, 3Department of Immunology, Genetics and Pathology,Uppsala University, Uppsala, Sweden, 44Unit of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: rheumatoid arthritis (RA) and toll-like receptors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Innate Immunity and Rheumatic Disease Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: RA patients with antibodies against collagen
type II (CII) have a distinct acute onset RA phenotype, associated with
cytokine induction by surface-bound anti-CII IC (Mullazehi A&R 2006,
Mullazehi ARD 2007, Mullazehi ART 2012). PMN
reactivity relate to early joint destruction in this phenotype (Manivel ART
2015). Hence we searched for CII-dependent mechanisms that might attract PMN to
the joint.

Methods:
Healthy donor PMN and peripheral
blood mononuclear cells (PBMC) were stimulated together (co-cultures) and
individually with surface-bound IC (anti-CII IC, tetanus toxoid (TT)/anti-TT
IC, plate-bound IgG) or GM-CSF. Blocking and neutralizing studies were
performed with antibodies against TLR4, FcgRIIa, FcgRIII and GM-CSF. Supernatant levels of
TNF-
a and CXCL8 were analyzed with ELISA.

Results: PMN alone produced negligible cytokine
levels. TNF-a production was downregulated
in all co-culture systems compared to PBMC cultures. CXCL8 levels were specifically
upregulated in anti-CII IC-stimulated co-cultures
compared to parallel PBMC cultures (fig 1). The anti-CII IC augmentation of
CXCL8 was dependent on CII, as CXCL8 production was downregulated
in co-cultures stimulated with the other IC; plate-bound
IgG (fig 1) or TT/anti-TT IC (not shown). Blocking and neutralization studies
showed that the increase of CXCL8 in anti-CII IC stimulated co-cultures was
totally dependent on TLR4, partly on PMN enzymes (fig 2), FcgRIIa, FcgRIII (fig 3), and density of anti-CII
in IC. Like anti-CII IC, GM-CSF alone also induced co-culture-dependent CXCL8
enhancement (fig 1), and GM-CSF neutralization abrogated the anti-CII
IC-dependent CXCL8 enhancement (fig 3).

Conclusion: In anti-CII-positive RA patients, PMN amplify
local inflammation by inducing CXCL8. This mechanism
is dependent on TLR4, PMN enzymes, GM-CSF and the joint-specific autoantigen
CII. Local TLR4 blockade, PMN enzyme inhibition or GM-CSF neutralization might
be used to suppress acute joint inflammation.

Figure:1

Figure:2

Figure:3


Disclosure: V. A. Manivel, None; A. Sohrabian, None; J. Rönnelid, None.

To cite this abstract in AMA style:

Manivel VA, Sohrabian A, Rönnelid J. PMN Reactivity Contribute to Acute Onset Joint Inflammation By Increasing CXCL8 Production in Joints of RA Patients with Anti-Collagen II Antibodies [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/pmn-reactivity-contribute-to-acute-onset-joint-inflammation-by-increasing-cxcl8-production-in-joints-of-ra-patients-with-anti-collagen-ii-antibodies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pmn-reactivity-contribute-to-acute-onset-joint-inflammation-by-increasing-cxcl8-production-in-joints-of-ra-patients-with-anti-collagen-ii-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology